Skip to main content
PMC home page
Heart logoLink to Heart
. 1999 Mar;81(3):232–238. doi: 10.1136/hrt.81.3.232

Chlamydia pneumoniae and atherosclerosis

Y Wong 1, P Gallagher 1, M Ward 1
PMCID: PMC1728972  PMID: 10026342

Abstract

OBJECTIVE—To review the literature for evidence that chronic infection with Chlamydia pneumoniae is associated with atherosclerosis and acute coronary syndromes. 
DATA SOURCES—MEDLINE and Institute of Science and Information bibliographic databases were searched at the end of September 1998. Indexing terms used were chlamydi*, heart, coronary, and atherosclerosis. Serological and pathological studies published as papers in any language since 1988 or abstracts since 1997 were selected.
DATA EXTRACTION—It was assumed that chronic C pneumoniae infection is characterised by the presence of both specific IgG and IgA, and serological studies were examined for associations that fulfilled these criteria. Pathological studies were also reviewed for evidence that the presence of C pneumoniae in diseased vessels is associated with the severity and extent of atherosclerosis. 
DATA SYNTHESIS—The majority of serological studies have shown an association between C pneumoniae and atherosclerosis. However, the number of cases in studies that have reported a positive association when using strict criteria for chronic infection is similar to the number of cases in studies which found no association. Nevertheless, the organism is widely found in atherosclerotic vessels, although it may not be at all diseased sites and is not confined to the most severe lesions. Rabbit models and preliminary antibiotic trials suggest that the organism might exacerbate atherosclerosis.
CONCLUSION—More evidence is required before C pneumoniae can be accepted as playing a role in atherosclerosis. Although use of antibiotics in routine practice is not justified, large scale trials in progress will help to elucidate the role of C pneumoniae.



Full Text

The Full Text of this article is available as a PDF (138.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

Age standardised attack rates per 100 000 population in men (A) and women (B) for coronary events (definite and probable myocardial infarction and coronary deaths) in two regions of east Finland and prevalence of C pneumoniae IgG.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldous M. B., Grayston J. T., Wang S. P., Foy H. M. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis. 1992 Sep;166(3):646–649. doi: 10.1093/infdis/166.3.646. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. L., Carlquist J. F., Muhlestein J. B., Horne B. D., Elmer S. P. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 1998 Jul;32(1):35–41. doi: 10.1016/s0735-1097(98)00203-4. [DOI] [PubMed] [Google Scholar]
  3. Blasi F., Cosentini R., Raccanelli R., Massari F. M., Arosio C., Tarsia P., Allegra L. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest. 1997 Aug;112(2):309–312. doi: 10.1378/chest.112.2.309. [DOI] [PubMed] [Google Scholar]
  4. Blasi F., Denti F., Erba M., Cosentini R., Raccanelli R., Rinaldi A., Fagetti L., Esposito G., Ruberti U., Allegra L. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996 Nov;34(11):2766–2769. doi: 10.1128/jcm.34.11.2766-2769.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boman J., Söderberg S., Forsberg J., Birgander L. S., Allard A., Persson K., Jidell E., Kumlin U., Juto P., Waldenström A. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis. 1998 Jul;178(1):274–277. doi: 10.1086/517452. [DOI] [PubMed] [Google Scholar]
  6. Campbell L. A., O'Brien E. R., Cappuccio A. L., Kuo C. C., Wang S. P., Stewart D., Patton D. L., Cummings P. K., Grayston J. T. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995 Aug;172(2):585–588. doi: 10.1093/infdis/172.2.585. [DOI] [PubMed] [Google Scholar]
  7. Chirgwin K., Roblin P. M., Gelling M., Hammerschlag M. R., Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis. 1991 Apr;163(4):757–761. doi: 10.1093/infdis/163.4.757. [DOI] [PubMed] [Google Scholar]
  8. Chiu B., Viira E., Tucker W., Fong I. W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997 Oct 7;96(7):2144–2148. doi: 10.1161/01.cir.96.7.2144. [DOI] [PubMed] [Google Scholar]
  9. Cook P. J., Honeybourne D., Lip G. Y., Beevers D. G., Wise R., Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke. 1998 Feb;29(2):404–410. doi: 10.1161/01.str.29.2.404. [DOI] [PubMed] [Google Scholar]
  10. Dahlén G. H., Boman J., Birgander L. S., Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis. 1995 Apr 24;114(2):165–174. doi: 10.1016/0021-9150(94)05480-7. [DOI] [PubMed] [Google Scholar]
  11. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997 Aug 9;350(9075):430–436. doi: 10.1016/S0140-6736(97)03079-1. [DOI] [PubMed] [Google Scholar]
  12. Davidson M., Kuo C. C., Middaugh J. P., Campbell L. A., Wang S. P., Newman W. P., 3rd, Finley J. C., Grayston J. T. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998 Aug 18;98(7):628–633. doi: 10.1161/01.cir.98.7.628. [DOI] [PubMed] [Google Scholar]
  13. Domeika M., Domeika K., Paavonen J., Mårdh P. A., Witkin S. S. Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease. J Infect Dis. 1998 Mar;177(3):714–719. doi: 10.1086/514218. [DOI] [PubMed] [Google Scholar]
  14. Einarsson S., Sigurdsson H. K., Magnusdottir S. D., Erlendsdottir H., Briem H., Gudmundsson S. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis. 1994;26(4):393–397. doi: 10.3109/00365549409008610. [DOI] [PubMed] [Google Scholar]
  15. Fong I. W., Chiu B., Viira E., Fong M. W., Jang D., Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997 Jan;35(1):48–52. doi: 10.1128/jcm.35.1.48-52.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gaydos C. A., Summersgill J. T., Sahney N. N., Ramirez J. A., Quinn T. C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996 May;64(5):1614–1620. doi: 10.1128/iai.64.5.1614-1620.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grayston J. T. Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. Circulation. 1998 May 5;97(17):1669–1670. doi: 10.1161/01.cir.97.17.1669. [DOI] [PubMed] [Google Scholar]
  18. Grayston J. T. Chlamydia pneumoniae, strain TWAR. Chest. 1989 Mar;95(3):664–669. doi: 10.1378/chest.95.3.664. [DOI] [PubMed] [Google Scholar]
  19. Grayston J. T., Kuo C. C., Coulson A. S., Campbell L. A., Lawrence R. D., Lee M. J., Strandness E. D., Wang S. P. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995 Dec 15;92(12):3397–3400. doi: 10.1161/01.cir.92.12.3397. [DOI] [PubMed] [Google Scholar]
  20. Grayston J. T., Kuo C. C., Wang S. P., Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986 Jul 17;315(3):161–168. doi: 10.1056/NEJM198607173150305. [DOI] [PubMed] [Google Scholar]
  21. Grayston J. T., Mordhorst C., Bruu A. L., Vene S., Wang S. P. Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983. J Infect Dis. 1989 Jun;159(6):1111–1114. doi: 10.1093/infdis/159.6.1111. [DOI] [PubMed] [Google Scholar]
  22. Gupta S., Leatham E. W., Carrington D., Mendall M. A., Kaski J. C., Camm A. J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997 Jul 15;96(2):404–407. doi: 10.1161/01.cir.96.2.404. [DOI] [PubMed] [Google Scholar]
  23. Gurfinkel E., Bozovich G., Daroca A., Beck E., Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet. 1997 Aug 9;350(9075):404–407. doi: 10.1016/s0140-6736(97)07201-2. [DOI] [PubMed] [Google Scholar]
  24. Halme S., Syrjälä H., Bloigu A., Saikku P., Leinonen M., Airaksinen J., Surcel H. M. Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease. Eur Heart J. 1997 Jul;18(7):1095–1101. doi: 10.1093/oxfordjournals.eurheartj.a015403. [DOI] [PubMed] [Google Scholar]
  25. Hyman C. L., Augenbraun M. H., Roblin P. M., Schachter J., Hammerschlag M. R. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J Clin Microbiol. 1991 Sep;29(9):2082–2083. doi: 10.1128/jcm.29.9.2082-2083.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jackson L. A., Campbell L. A., Kuo C. C., Rodriguez D. I., Lee A., Grayston J. T. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997 Jul;176(1):292–295. doi: 10.1086/517270. [DOI] [PubMed] [Google Scholar]
  27. Jackson L. A., Campbell L. A., Schmidt R. A., Kuo C. C., Cappuccio A. L., Lee M. J., Grayston J. T. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997 May;150(5):1785–1790. [PMC free article] [PubMed] [Google Scholar]
  28. Juvonen J., Juvonen T., Laurila A., Alakärppä H., Lounatmaa K., Surcel H. M., Leinonen M., Kairaluoma M. I., Saikku P. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 1997 Mar;25(3):499–505. doi: 10.1016/s0741-5214(97)70260-x. [DOI] [PubMed] [Google Scholar]
  29. Kalayoglu M. V., Byrne G. I. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998 Mar;177(3):725–729. doi: 10.1086/514241. [DOI] [PubMed] [Google Scholar]
  30. Kanamoto Y., Ouchi K., Mizui M., Ushio M., Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in japan. J Clin Microbiol. 1991 Apr;29(4):816–818. doi: 10.1128/jcm.29.4.816-818.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kark J. D., Leinonen M., Paltiel O., Saikku P. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol. 1997 Aug;26(4):730–738. doi: 10.1093/ije/26.4.730. [DOI] [PubMed] [Google Scholar]
  32. Karvonen M., Tuomilehto J., Pitkäniemi J., Naukkarinen A., Saikku P. Chlamydia pneumoniae IgG antibody prevalence in south-western and eastern Finland in 1982 and 1987. Int J Epidemiol. 1994 Feb;23(1):176–184. doi: 10.1093/ije/23.1.176. [DOI] [PubMed] [Google Scholar]
  33. Karvonen M., Tuomilehto J., Pitkäniemi J., Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987. Epidemiol Infect. 1993 Apr;110(2):349–360. doi: 10.1017/s0950268800068291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kern D. G., Neill M. A., Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest. 1993 Jul;104(1):208–213. doi: 10.1378/chest.104.1.208. [DOI] [PubMed] [Google Scholar]
  35. Kol A., Sukhova G. K., Lichtman A. H., Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation. 1998 Jul 28;98(4):300–307. doi: 10.1161/01.cir.98.4.300. [DOI] [PubMed] [Google Scholar]
  36. Kuo C. C., Coulson A. S., Campbell L. A., Cappuccio A. L., Lawrence R. D., Wang S. P., Grayston J. T. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg. 1997 Jul;26(1):29–31. doi: 10.1016/s0741-5214(97)70143-5. [DOI] [PubMed] [Google Scholar]
  37. Kuo C. C., Gown A. M., Benditt E. P., Grayston J. T. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1993 Oct;13(10):1501–1504. doi: 10.1161/01.atv.13.10.1501. [DOI] [PubMed] [Google Scholar]
  38. Kuo C. C., Grayston J. T., Campbell L. A., Goo Y. A., Wissler R. W., Benditt E. P. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6911–6914. doi: 10.1073/pnas.92.15.6911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kuo C. C., Shor A., Campbell L. A., Fukushi H., Patton D. L., Grayston J. T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993 Apr;167(4):841–849. doi: 10.1093/infdis/167.4.841. [DOI] [PubMed] [Google Scholar]
  40. Laitinen K., Laurila A., Pyhälä L., Leinonen M., Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997 Nov;65(11):4832–4835. doi: 10.1128/iai.65.11.4832-4835.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Leinonen M., Linnanmäki E., Mattila K., Nieminen M. S., Valtonen V., Leirisalo-Repo M., Saikku P. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog. 1990 Jul;9(1):67–73. doi: 10.1016/0882-4010(90)90042-o. [DOI] [PubMed] [Google Scholar]
  42. Lindholt J. S., Ostergård L., Henneberg E. W., Fasting H., Andersen P. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg. 1998 Feb;15(2):161–164. doi: 10.1016/s1078-5884(98)80138-x. [DOI] [PubMed] [Google Scholar]
  43. Linnanmäki E., Leinonen M., Mattila K., Nieminen M. S., Valtonen V., Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993 Apr;87(4):1130–1134. doi: 10.1161/01.cir.87.4.1130. [DOI] [PubMed] [Google Scholar]
  44. Maass M., Bartels C., Engel P. M., Mamat U., Sievers H. H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998 Mar 15;31(4):827–832. doi: 10.1016/s0735-1097(98)00016-3. [DOI] [PubMed] [Google Scholar]
  45. Maass M., Krause E., Engel P. M., Krüger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology. 1997 Aug;48(8):699–706. doi: 10.1177/000331979704800805. [DOI] [PubMed] [Google Scholar]
  46. Maurin M., Eb F., Etienne J., Raoult D. Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol. 1997 Sep;35(9):2283–2287. doi: 10.1128/jcm.35.9.2283-2287.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mazzoli S., Tofani N., Fantini A., Semplici F., Bandini F., Salvi A., Vergassola R. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J. 1998 Jan;135(1):15–20. doi: 10.1016/s0002-8703(98)70337-0. [DOI] [PubMed] [Google Scholar]
  48. Mehta J. L., Saldeen T. G., Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 1998 May;31(6):1217–1225. doi: 10.1016/s0735-1097(98)00093-x. [DOI] [PubMed] [Google Scholar]
  49. Melnick S. L., Shahar E., Folsom A. R., Grayston J. T., Sorlie P. D., Wang S. P., Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med. 1993 Nov;95(5):499–504. doi: 10.1016/0002-9343(93)90332-j. [DOI] [PubMed] [Google Scholar]
  50. Mendall M. A., Carrington D., Strachan D., Patel P., Molineaux N., Levi J., Toosey T., Camm A. J., Northfield T. C. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995 Mar;30(2):121–128. doi: 10.1016/s0163-4453(95)80006-9. [DOI] [PubMed] [Google Scholar]
  51. Miettinen H., Lehto S., Saikku P., Haffner S. M., Rönnemaa T., Pyörälä K., Laakso M. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J. 1996 May;17(5):682–688. doi: 10.1093/oxfordjournals.eurheartj.a014934. [DOI] [PubMed] [Google Scholar]
  52. Moazed T. C., Kuo C., Patton D. L., Grayston J. T., Campbell L. A. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol. 1996 Feb;148(2):667–676. [PMC free article] [PubMed] [Google Scholar]
  53. Muhlestein J. B., Anderson J. L., Hammond E. H., Zhao L., Trehan S., Schwobe E. P., Carlquist J. F. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998 Feb 24;97(7):633–636. doi: 10.1161/01.cir.97.7.633. [DOI] [PubMed] [Google Scholar]
  54. Muhlestein J. B., Hammond E. H., Carlquist J. F., Radicke E., Thomson M. J., Karagounis L. A., Woods M. L., Anderson J. L. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996 Jun;27(7):1555–1561. doi: 10.1016/0735-1097(96)00055-1. [DOI] [PubMed] [Google Scholar]
  55. Naidu B. R., Ngeow Y. F., Kannan P., Jeyamalar R., Khir A., Khoo K. L., Pang T. Evidence of Chlamydia pneumoniae infection obtained by the polymerase chain reaction (PCR) in patients with acute myocardial infarction and coronary heart disease. J Infect. 1997 Sep;35(2):199–200. doi: 10.1016/s0163-4453(97)92040-5. [DOI] [PubMed] [Google Scholar]
  56. Ong G., Thomas B. J., Mansfield A. O., Davidson B. R., Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996 Feb;49(2):102–106. doi: 10.1136/jcp.49.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Ossewaarde J. M., Feskens E. J., De Vries A., Vallinga C. E., Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect. 1998 Feb;120(1):93–99. doi: 10.1017/s0950268897008303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Patel P., Mendall M. A., Carrington D., Strachan D. P., Leatham E., Molineaux N., Levy J., Blakeston C., Seymour C. A., Camm A. J. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995 Sep 16;311(7007):711–714. doi: 10.1136/bmj.311.7007.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Paterson D. L., Hall J., Rasmussen S. J., Timms P. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology. 1998 May;30(2):169–172. doi: 10.1080/00313029800169166. [DOI] [PubMed] [Google Scholar]
  60. Petersen E., Boman J., Persson K., Arnerlöv C., Wadell G., Juto P., Eriksson A., Dahlén G., Angquist K. A. Chlamydia pneumoniae in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1998 Feb;15(2):138–142. doi: 10.1016/s1078-5884(98)80134-2. [DOI] [PubMed] [Google Scholar]
  61. Ramirez J. A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med. 1996 Dec 15;125(12):979–982. doi: 10.7326/0003-4819-125-12-199612150-00008. [DOI] [PubMed] [Google Scholar]
  62. Saikku P., Leinonen M., Mattila K., Ekman M. R., Nieminen M. S., Mäkelä P. H., Huttunen J. K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988 Oct 29;2(8618):983–986. doi: 10.1016/s0140-6736(88)90741-6. [DOI] [PubMed] [Google Scholar]
  63. Saikku P., Leinonen M., Tenkanen L., Linnanmäki E., Ekman M. R., Manninen V., Mänttäri M., Frick M. H., Huttunen J. K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992 Feb 15;116(4):273–278. doi: 10.7326/0003-4819-116-4-273. [DOI] [PubMed] [Google Scholar]
  64. Salomaa V., Arstila M., Kaarsalo E., Ketonen M., Kuulasmaa K., Lehto S., Miettinen H., Mustaniemi H., Niemelä M., Palomäki P. Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. Am J Epidemiol. 1992 Dec 1;136(11):1303–1315. doi: 10.1093/oxfordjournals.aje.a116442. [DOI] [PubMed] [Google Scholar]
  65. Schett G., Metzler B., Mayr M., Amberger A., Niederwieser D., Gupta R. S., Mizzen L., Xu Q., Wick G. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis. 1997 Jan 3;128(1):27–38. doi: 10.1016/s0021-9150(96)05975-8. [DOI] [PubMed] [Google Scholar]
  66. Shen C. L., Purewal M., San Francisco S., Pence B. C. Absence of PhIP adducts, p53 and Apc mutations, in rats fed a cooked beef diet containing a high level of heterocyclic amines. Nutr Cancer. 1998;30(3):227–231. doi: 10.1080/01635589809514668. [DOI] [PubMed] [Google Scholar]
  67. Shor A., Kuo C. C., Patton D. L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992 Sep;82(3):158–161. [PubMed] [Google Scholar]
  68. Sinisalo J., Mattila K., Nieminen M. S., Valtonen V., Syrjälä M., Sundberg S., Saikku P. The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production. J Antimicrob Chemother. 1998 Jan;41(1):85–92. doi: 10.1093/jac/41.1.85. [DOI] [PubMed] [Google Scholar]
  69. Taylor-Robinson D., Ong G., Thomas B. J., Rose M. L., Yacoub M. H. Chlamydia pneumoniae in vascular tissues from heart-transplant donors. Lancet. 1998 Apr 25;351(9111):1255–1255. doi: 10.1016/S0140-6736(05)79322-3. [DOI] [PubMed] [Google Scholar]
  70. Tejada C., Strong J. P., Montenegro M. R., Restrepo C., Solberg L. A. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 1968 May;18(5):509–526. [PubMed] [Google Scholar]
  71. Thom D. H., Grayston J. T., Siscovick D. S., Wang S. P., Weiss N. S., Daling J. R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992 Jul 1;268(1):68–72. [PubMed] [Google Scholar]
  72. Thom D. H., Wang S. P., Grayston J. T., Siscovick D. S., Stewart D. K., Kronmal R. A., Weiss N. S. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 1991 May-Jun;11(3):547–551. doi: 10.1161/01.atv.11.3.547. [DOI] [PubMed] [Google Scholar]
  73. Thomas G. N., Scheel O., Koehler A. P., Bassett D. C., Cheng A. F. Respiratory Chlamydial infections in a Hong Kong teaching hospital and association with coronary heart disease. Scand J Infect Dis Suppl. 1997;104:30–33. [PubMed] [Google Scholar]
  74. Toss H., Gnarpe J., Gnarpe H., Siegbahn A., Lindahl B., Wallentin L. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J. 1998 Apr;19(4):570–577. doi: 10.1053/euhj.1997.0771. [DOI] [PubMed] [Google Scholar]
  75. Weiss S. M., Roblin P. M., Gaydos C. A., Cummings P., Patton D. L., Schulhoff N., Shani J., Frankel R., Penney K., Quinn T. C. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996 Apr;173(4):957–962. doi: 10.1093/infdis/173.4.957. [DOI] [PubMed] [Google Scholar]
  76. Wimmer M. L., Sandmann-Strupp R., Saikku P., Haberl R. L. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996 Dec;27(12):2207–2210. doi: 10.1161/01.str.27.12.2207. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES